To gain further insights into the molecular mechanisms accounting for this loss of NK cell function, we focused our study on TET2 mutated patients, excluding the IDH mutated patients from our cohort, and interrogated whether NK and MDS cells could share TET2 mutations. The gene discussed is IDH1; the disease is myelodysplastic syndrome.